TFF Pharmaceuticals, Inc.
- Raised $26 million (2020)
- 5 clinical trials
- Research grants: $864,948
- Founded 2018
Life science companies
Explore 34,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Arch Therapeutics, Inc.
- Raised $4.2 million (2022)
- 2 clinical trials
- FDA-cleared or approved devices
- Founded 2006
Co-Diagnostics, Inc.
Nasdaq: CODX
- Raised $47 million (2022)
- 1 FDA-registered device site
- Founded 2013
InkSpace Imaging, Inc.
- Raised $12 million (2023)
- FDA-cleared or approved devices
- Research grants: $3.8 million
Paragon 28, Inc.
- Raised $200,000 (2011)
- 8 clinical trials, 1 active
- FDA-cleared or approved devices
- Founded 2011
Lifecore Biomedical
On BioBridgeX
- 1 FDA-registered device site
- 1 FDA-registered drug site
Minerva Surgical Inc
- Raised $15 million (2020)
- 6 clinical trials
- FDA-cleared or approved devices
March Biosciences, Inc.
- Raised $22 million (2024)
- 2 clinical trials, 2 active
- Research grants: $7.4 million
- Founded 2021
Avalo Therapeutics, Inc.
Nasdaq: AVTX
- Raised $131 million (2024)
- 10 clinical trials
- Founded 2011
Quince Therapeutics, Inc.
Nasdaq: QNCX
- Raised $115 million (2026)
- 10 clinical trials
- Founded 2012
Albireo Pharma, Inc.
- Raised $19 million (2012)
- 27 clinical trials
- Research grants: $1.2 million
Metritrack,Inc.
- Raised $325,000 (2018)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $411,058
ReAlta Life Sciences, Inc.
- Raised $25 million (2025)
- 6 clinical trials, 3 active
- Research grants: $3 million
- Founded 2018
RESTOR3D, Inc.
- Raised $85 million (2025)
- 24 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2017
LivaNova PLC
Nasdaq: LIVN
- 43 clinical trials, 2 active
- Founded 2015
Xenoport Inc
- Raised $20 million (2012)
- 27 clinical trials
- Research grants: $1.3 million
Altor Bioscience Corp
- Raised $30 million (2017)
- 15 clinical trials
- Research grants: $24 million
Lemaitre Vascular Inc
Nasdaq: LMAT
- 8 clinical trials, 5 active
- FDA-cleared or approved devices
Tenax Therapeutics, Inc.
Nasdaq: TENX
- Raised $100 million (2024)
- 9 clinical trials, 3 active
- Founded 2008
Verrica Pharmaceuticals Inc.
Nasdaq: VRCA
- Raised $50 million (2025)
- 9 clinical trials, 3 active
- Founded 2013
Showing 420 of 34,266 companies
Load morePublished company profiles only; counts update daily. Data licences